Wikisage, the free encyclopedia of the second generation, is digital heritage
Epilepsy
Classification of ethiology could divided in four categories:
- idiopathic epilepsy
- symptomatic epilepsy
- provoked epilepsy
- cryptogenic epilepsy
[1] It is difficult to distinguish between genetic and cryptogenic syndromes.
Morbility data is difficult to interpret when WHO[2] states 50 millions persons suffers epilepsy[3]
nonadherence appears to be associated with increased health care costs, nevertheless XR-medicine appears as strategy to overcome compliance wih AED[4]
|
Medicines | ||||
| type | ,,, | ,,,, | ||
| INN | Generic | slow release | ||
| carbamazepine | normal | xr | ||
| lamotrigine | normal | xr | ||
| levetiracetam | normal | xr | ||
| oxcarbazepine | ... | xr | ||
| phenitoin | ... | xr | ||
| valproate | xr | |||
| topiramate | xr | |||
|
AED | ||||
ILAE Classification
[5] [6] [7] Berg et al.2010 Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009 Epilepsia 51 676-685
See also
A new perspective for Epileptic Disorders
Links
Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population
| References: |